Liposomes: vehicles for the targeted and controlled delivery of peptides and proteins
Identifieur interne : 002884 ( Main/Exploration ); précédent : 002883; suivant : 002885Liposomes: vehicles for the targeted and controlled delivery of peptides and proteins
Auteurs : D. J. A Crommelin [Pays-Bas] ; T. Daemen [Pays-Bas] ; G. L Scherphof [Pays-Bas] ; M. H Vingerhoeds [Pays-Bas] ; J. L. M Heeremans [Pays-Bas] ; C. Kluft [Pays-Bas] ; G. Storm [Pays-Bas]Source :
- Journal of Controlled Release [ 0168-3659 ] ; 1997.
English descriptors
- Teeft :
- Acta, Biochim, Biophys, Blood cells, Blood circulation, Boca raton, Carcinoma, Crommelin, Daemen, Doxorubicin, Endothelial cells, Enzyme prodrug therapy, Groningen, Heeremans, Homing, Homing device, Immunoliposomes, Immunomodulators, Intravenous administration, Kluft, Larger cells, Liposomal, Liposomal delivery, Liposomal doxorubicin, Liposomal muramyl dipeptide, Liposome, Liver macrophage population, Liver macrophages, Liver metastases, Macrophage, Macrophage activation, Macrophage population, Marcel dekker, Metastasis, Monoclonal antibody, Mononuclear phagocyte system, Muramyl, Murine liver metastases, Ovarian carcinoma cells, Peptide, Peritoneal, Peritoneal cavity, Phagocytic, Phagocytic capacity, Physiological chemistry, Plasminogen, Plasminogen activator, Prodrug, Release kinetics, Scherphof, Target cell, Target cells, Target site, Target sites, Therapeutic effect, Tumor cells, Tumor challenge, Tumor cytotoxicity, Tumoricidal, Tumoricidal activity, Tumoricidal response, Unconjugated liposomes, Utrecht, Utrecht university, Vingerhoeds.
Abstract
Abstract: Several approaches are presented that have been developed for the liposomal delivery of peptides and proteins. For a rational design of targeted liposomes, the anatomical and physiological constraints with respect to the distribution of liposomes in the body have to be taken into account. Target sites that offer exciting opportunities are located in the blood compartments (e.g. thrombi, endothelium), in the liver (e.g. macrophages), in the peritoneal cavity (e.g. tumor cells), or in diseased tissues (e.g. inflammations or tumors). Examples of ongoing liposome-related research in our institutes are discussed.
Url:
DOI: 10.1016/S0168-3659(96)01583-0
Affiliations:
- Pays-Bas
- Groningue (province), Hollande-Méridionale, Utrecht (province)
- Groningue (ville), Leyde, Utrecht
- Université d'Utrecht, Université de Groningue
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001B05
- to stream Istex, to step Curation: 001B05
- to stream Istex, to step Checkpoint: 001677
- to stream Main, to step Merge: 002933
- to stream Main, to step Curation: 002884
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Liposomes: vehicles for the targeted and controlled delivery of peptides and proteins</title>
<author><name sortKey="Crommelin, D J A" sort="Crommelin, D J A" uniqKey="Crommelin D" first="D. J. A" last="Crommelin">D. J. A Crommelin</name>
</author>
<author><name sortKey="Daemen, T" sort="Daemen, T" uniqKey="Daemen T" first="T" last="Daemen">T. Daemen</name>
</author>
<author><name sortKey="Scherphof, G L" sort="Scherphof, G L" uniqKey="Scherphof G" first="G. L" last="Scherphof">G. L Scherphof</name>
</author>
<author><name sortKey="Vingerhoeds, M H" sort="Vingerhoeds, M H" uniqKey="Vingerhoeds M" first="M. H" last="Vingerhoeds">M. H Vingerhoeds</name>
</author>
<author><name sortKey="Heeremans, J L M" sort="Heeremans, J L M" uniqKey="Heeremans J" first="J. L. M" last="Heeremans">J. L. M Heeremans</name>
</author>
<author><name sortKey="Kluft, C" sort="Kluft, C" uniqKey="Kluft C" first="C" last="Kluft">C. Kluft</name>
</author>
<author><name sortKey="Storm, G" sort="Storm, G" uniqKey="Storm G" first="G" last="Storm">G. Storm</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:009AE18C427F3F84A8B9C01676A0EC7748699601</idno>
<date when="1997" year="1997">1997</date>
<idno type="doi">10.1016/S0168-3659(96)01583-0</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-8903H9GW-Q/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001B05</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001B05</idno>
<idno type="wicri:Area/Istex/Curation">001B05</idno>
<idno type="wicri:Area/Istex/Checkpoint">001677</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001677</idno>
<idno type="wicri:doubleKey">0168-3659:1997:Crommelin D:liposomes:vehicles:for</idno>
<idno type="wicri:Area/Main/Merge">002933</idno>
<idno type="wicri:Area/Main/Curation">002884</idno>
<idno type="wicri:Area/Main/Exploration">002884</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Liposomes: vehicles for the targeted and controlled delivery of peptides and proteins</title>
<author><name sortKey="Crommelin, D J A" sort="Crommelin, D J A" uniqKey="Crommelin D" first="D. J. A" last="Crommelin">D. J. A Crommelin</name>
<affiliation wicri:level="4"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Dept. Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, P.O. Box 80082, 3508 TB Utrecht</wicri:regionArea>
<orgName type="university">Université d'Utrecht</orgName>
<placeName><settlement type="city">Utrecht</settlement>
<region nuts="2">Utrecht (province)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Daemen, T" sort="Daemen, T" uniqKey="Daemen T" first="T" last="Daemen">T. Daemen</name>
<affiliation wicri:level="4"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Lab. Physiological Chemistry, Groningen Institute for Drug Studies, University of Groningen, A. Deusinglaan 1, 9713 AV Groningen</wicri:regionArea>
<orgName type="university">Université de Groningue</orgName>
<placeName><settlement type="city">Groningue (ville)</settlement>
<region>Groningue (province)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Scherphof, G L" sort="Scherphof, G L" uniqKey="Scherphof G" first="G. L" last="Scherphof">G. L Scherphof</name>
<affiliation wicri:level="4"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Lab. Physiological Chemistry, Groningen Institute for Drug Studies, University of Groningen, A. Deusinglaan 1, 9713 AV Groningen</wicri:regionArea>
<orgName type="university">Université de Groningue</orgName>
<placeName><settlement type="city">Groningue (ville)</settlement>
<region>Groningue (province)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vingerhoeds, M H" sort="Vingerhoeds, M H" uniqKey="Vingerhoeds M" first="M. H" last="Vingerhoeds">M. H Vingerhoeds</name>
<affiliation wicri:level="4"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Dept. Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, P.O. Box 80082, 3508 TB Utrecht</wicri:regionArea>
<orgName type="university">Université d'Utrecht</orgName>
<placeName><settlement type="city">Utrecht</settlement>
<region nuts="2">Utrecht (province)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Heeremans, J L M" sort="Heeremans, J L M" uniqKey="Heeremans J" first="J. L. M" last="Heeremans">J. L. M Heeremans</name>
<affiliation wicri:level="4"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Dept. Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, P.O. Box 80082, 3508 TB Utrecht</wicri:regionArea>
<orgName type="university">Université d'Utrecht</orgName>
<placeName><settlement type="city">Utrecht</settlement>
<region nuts="2">Utrecht (province)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kluft, C" sort="Kluft, C" uniqKey="Kluft C" first="C" last="Kluft">C. Kluft</name>
<affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Gaubius Laboratory, TNO-PG, P.O. Box 430, 2300 AK, Leiden</wicri:regionArea>
<placeName><settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Storm, G" sort="Storm, G" uniqKey="Storm G" first="G" last="Storm">G. Storm</name>
<affiliation wicri:level="4"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Dept. Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, P.O. Box 80082, 3508 TB Utrecht</wicri:regionArea>
<orgName type="university">Université d'Utrecht</orgName>
<placeName><settlement type="city">Utrecht</settlement>
<region nuts="2">Utrecht (province)</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Journal of Controlled Release</title>
<title level="j" type="abbrev">COREL</title>
<idno type="ISSN">0168-3659</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1997">1997</date>
<biblScope unit="volume">46</biblScope>
<biblScope unit="issue">1–2</biblScope>
<biblScope unit="page" from="165">165</biblScope>
<biblScope unit="page" to="175">175</biblScope>
</imprint>
<idno type="ISSN">0168-3659</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0168-3659</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acta</term>
<term>Biochim</term>
<term>Biophys</term>
<term>Blood cells</term>
<term>Blood circulation</term>
<term>Boca raton</term>
<term>Carcinoma</term>
<term>Crommelin</term>
<term>Daemen</term>
<term>Doxorubicin</term>
<term>Endothelial cells</term>
<term>Enzyme prodrug therapy</term>
<term>Groningen</term>
<term>Heeremans</term>
<term>Homing</term>
<term>Homing device</term>
<term>Immunoliposomes</term>
<term>Immunomodulators</term>
<term>Intravenous administration</term>
<term>Kluft</term>
<term>Larger cells</term>
<term>Liposomal</term>
<term>Liposomal delivery</term>
<term>Liposomal doxorubicin</term>
<term>Liposomal muramyl dipeptide</term>
<term>Liposome</term>
<term>Liver macrophage population</term>
<term>Liver macrophages</term>
<term>Liver metastases</term>
<term>Macrophage</term>
<term>Macrophage activation</term>
<term>Macrophage population</term>
<term>Marcel dekker</term>
<term>Metastasis</term>
<term>Monoclonal antibody</term>
<term>Mononuclear phagocyte system</term>
<term>Muramyl</term>
<term>Murine liver metastases</term>
<term>Ovarian carcinoma cells</term>
<term>Peptide</term>
<term>Peritoneal</term>
<term>Peritoneal cavity</term>
<term>Phagocytic</term>
<term>Phagocytic capacity</term>
<term>Physiological chemistry</term>
<term>Plasminogen</term>
<term>Plasminogen activator</term>
<term>Prodrug</term>
<term>Release kinetics</term>
<term>Scherphof</term>
<term>Target cell</term>
<term>Target cells</term>
<term>Target site</term>
<term>Target sites</term>
<term>Therapeutic effect</term>
<term>Tumor cells</term>
<term>Tumor challenge</term>
<term>Tumor cytotoxicity</term>
<term>Tumoricidal</term>
<term>Tumoricidal activity</term>
<term>Tumoricidal response</term>
<term>Unconjugated liposomes</term>
<term>Utrecht</term>
<term>Utrecht university</term>
<term>Vingerhoeds</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: Several approaches are presented that have been developed for the liposomal delivery of peptides and proteins. For a rational design of targeted liposomes, the anatomical and physiological constraints with respect to the distribution of liposomes in the body have to be taken into account. Target sites that offer exciting opportunities are located in the blood compartments (e.g. thrombi, endothelium), in the liver (e.g. macrophages), in the peritoneal cavity (e.g. tumor cells), or in diseased tissues (e.g. inflammations or tumors). Examples of ongoing liposome-related research in our institutes are discussed.</div>
</front>
</TEI>
<affiliations><list><country><li>Pays-Bas</li>
</country>
<region><li>Groningue (province)</li>
<li>Hollande-Méridionale</li>
<li>Utrecht (province)</li>
</region>
<settlement><li>Groningue (ville)</li>
<li>Leyde</li>
<li>Utrecht</li>
</settlement>
<orgName><li>Université d'Utrecht</li>
<li>Université de Groningue</li>
</orgName>
</list>
<tree><country name="Pays-Bas"><region name="Utrecht (province)"><name sortKey="Crommelin, D J A" sort="Crommelin, D J A" uniqKey="Crommelin D" first="D. J. A" last="Crommelin">D. J. A Crommelin</name>
</region>
<name sortKey="Daemen, T" sort="Daemen, T" uniqKey="Daemen T" first="T" last="Daemen">T. Daemen</name>
<name sortKey="Heeremans, J L M" sort="Heeremans, J L M" uniqKey="Heeremans J" first="J. L. M" last="Heeremans">J. L. M Heeremans</name>
<name sortKey="Kluft, C" sort="Kluft, C" uniqKey="Kluft C" first="C" last="Kluft">C. Kluft</name>
<name sortKey="Scherphof, G L" sort="Scherphof, G L" uniqKey="Scherphof G" first="G. L" last="Scherphof">G. L Scherphof</name>
<name sortKey="Storm, G" sort="Storm, G" uniqKey="Storm G" first="G" last="Storm">G. Storm</name>
<name sortKey="Vingerhoeds, M H" sort="Vingerhoeds, M H" uniqKey="Vingerhoeds M" first="M. H" last="Vingerhoeds">M. H Vingerhoeds</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002884 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002884 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:009AE18C427F3F84A8B9C01676A0EC7748699601 |texte= Liposomes: vehicles for the targeted and controlled delivery of peptides and proteins }}
This area was generated with Dilib version V0.6.33. |